A detailed history of Alliancebernstein L.P. transactions in Cytokinetics Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,661,014 shares of CYTK stock, worth $81.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,661,014
Previous 1,879,161 11.61%
Holding current value
$81.2 Million
Previous $102 Million 13.86%
% of portfolio
0.03%
Previous 0.04%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$51.22 - $60.16 $11.2 Million - $13.1 Million
-218,147 Reduced 11.61%
1,661,014 $87.7 Million
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $5.22 Million - $8.19 Million
109,096 Added 6.16%
1,879,161 $102 Million
Q1 2024

May 14, 2024

BUY
$63.75 - $108.06 $105 Million - $178 Million
1,647,818 Added 1347.94%
1,770,065 $124 Million
Q4 2023

Feb 14, 2024

SELL
$26.88 - $83.49 $213,615 - $663,495
-7,947 Reduced 6.1%
122,247 $10.2 Million
Q3 2023

Nov 14, 2023

SELL
$29.46 - $36.61 $1.11 Million - $1.38 Million
-37,729 Reduced 22.47%
130,194 $3.84 Million
Q2 2023

Aug 15, 2023

SELL
$32.62 - $40.75 $1.42 Million - $1.78 Million
-43,574 Reduced 20.6%
167,923 $5.48 Million
Q1 2023

May 15, 2023

SELL
$33.36 - $45.71 $464,771 - $636,831
-13,932 Reduced 6.18%
211,497 $7.44 Million
Q4 2022

Feb 14, 2023

SELL
$35.77 - $51.11 $428,023 - $611,582
-11,966 Reduced 5.04%
225,429 $10.3 Million
Q3 2022

Nov 15, 2022

SELL
$38.54 - $54.52 $2.31 Million - $3.27 Million
-59,915 Reduced 20.15%
237,395 $11.5 Million
Q2 2022

Aug 15, 2022

BUY
$33.93 - $48.92 $3.47 Million - $5 Million
102,243 Added 52.41%
297,310 $11.7 Million
Q1 2022

May 13, 2022

SELL
$29.74 - $46.0 $4.81 Million - $7.45 Million
-161,862 Reduced 45.35%
195,067 $7.18 Million
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $3.64 Million - $4.92 Million
106,047 Added 42.27%
356,929 $16.3 Million
Q3 2021

Nov 10, 2021

SELL
$18.54 - $35.74 $3.81 Million - $7.35 Million
-205,592 Reduced 45.04%
250,882 $8.97 Million
Q2 2021

Jul 30, 2021

BUY
$19.79 - $26.99 $1.86 Million - $2.54 Million
94,150 Added 25.99%
456,474 $9.03 Million
Q1 2021

May 06, 2021

BUY
$18.57 - $25.68 $4.84 Million - $6.7 Million
260,794 Added 256.86%
362,324 $8.43 Million
Q3 2020

Nov 12, 2020

BUY
$20.58 - $28.96 $186,660 - $262,667
9,070 Added 9.81%
101,530 $2.2 Million
Q2 2020

Aug 13, 2020

BUY
$11.15 - $24.64 $276,074 - $610,086
24,760 Added 36.57%
92,460 $2.18 Million
Q1 2020

May 14, 2020

SELL
$8.75 - $16.3 $17,062 - $31,785
-1,950 Reduced 2.8%
67,700 $798,000
Q4 2019

Feb 18, 2020

BUY
$7.95 - $11.84 $20,272 - $30,192
2,550 Added 3.8%
69,650 $739,000
Q3 2019

Nov 14, 2019

SELL
$10.82 - $14.25 $140,660 - $185,250
-13,000 Reduced 16.23%
67,100 $764,000
Q2 2019

Aug 14, 2019

BUY
$7.95 - $11.25 $186,825 - $264,375
23,500 Added 41.52%
80,100 $901,000
Q2 2018

Aug 13, 2018

BUY
$6.9 - $9.9 $93,150 - $133,650
13,500 Added 31.32%
56,600 $470,000
Q1 2018

May 14, 2018

SELL
$7.2 - $10.05 $533,304 - $744,403
-74,070 Reduced 63.22%
43,100 $310,000
Q4 2017

Feb 13, 2018

SELL
$7.25 - $15.65 $33,350 - $71,990
-4,600 Reduced 3.78%
117,170 $955,000
Q3 2017

Nov 13, 2017

BUY
$12.0 - $15.0 $1.46 Million - $1.83 Million
121,770
121,770 $1.77 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.6B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.